Medicare Enrolled
Dr. Frederic Newman, MD
Gastroenterology · Pensacola, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Newman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Newman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Newman
Dr. Frederic Newman is a gastroenterology specialist in Pensacola, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Newman performed 2,137 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Newman received a total of $9,771 from 39 pharmaceutical and/or device companies across 253 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Newman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in FL
$9,771 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 126998 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,137
Medicare services
Top 12% in FL for gastroenterology
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,370 | $27 | $231 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
141 | $127 | $1,497 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
97 | $63 | $237 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
86 | $78 | $1,182 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
55 | $210 | $1,426 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $62 | $237 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $89 | $348 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $103 | $455 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
37 | $77 | $914 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
37 | $183 | $1,091 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
23 | $143 | $1,500 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
23 | $99 | $1,000 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
23 | $22 | $300 |
| Colon polyp removal with endoscope and cautery This procedure removes polyps or growths from the large bowel using a flexible tube with a camera. Electrical cautery is used to stop bleeding during the removal. |
19 | $158 | $1,503 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
18 | $40 | $131 |
| Dilation of esophagus | 17 | $41 | $825 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $98 | $542 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
16 | $172 | $1,109 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $66 | $343 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
65.2% high complexity
17.0% medium
17.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,771
Total received (2018-2024)
Avg $1,396/year across 7 years
Top 17% in FL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
253
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$501
2023
$2,722
2022
$900
2021
$834
2020
$509
2019
$563
2018
$3,742
Payments by company (2024)
ABBVIE INC.
$205
Janssen Biotech, Inc.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$88
Celgene Corporation
$33
Phathom Pharmaceuticals, Inc.
$32
Exact Sciences Corporation
$20
Olympus America Inc.
$15
PFIZER INC.
$13
Top 3 companies account for 77.3% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$2,800
Apollo Endosurgery US Inc
$1,671
ABBVIE INC.
$755
Janssen Biotech, Inc.
$633
Takeda Pharmaceuticals U.S.A., Inc.
$598
AbbVie Inc.
$498
AbbVie, Inc.
$494
E.R. Squibb & Sons, L.L.C.
$228
Gilead Sciences, Inc.
$217
Celgene Corporation
$176
Janssen Scientific Affairs, LLC
$171
PFIZER INC.
$168
Cook Medical LLC
$156
Synergy Pharmaceuticals Inc
$133
Ironwood Pharmaceuticals, Inc
$121
Covidien LP
$89
Boston Scientific Corporation
$86
Lumendi LLC
$86
Axonics, Inc.
$68
Ferring Pharmaceuticals Inc.
$58
Medtronic USA, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$50
Nestle HealthCare Nutrition Inc.
$48
Medtronic, Inc.
$39
Shionogi Inc
$37
Braintree Laboratories, Inc.
$34
Daiichi Sankyo Inc.
$34
Merck Sharp & Dohme Corporation
$34
Phathom Pharmaceuticals, Inc.
$32
Mallinckrodt Hospital Products Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Pharmacosmos Therapeutics Inc.
$23
Merck Sharp & Dohme LLC
$22
Exact Sciences Corporation
$20
NESTLE HEALTHCARE NUTRITION INC.
$19
Olympus America Inc.
$15
GENZYME CORPORATION
$15
Shire North American Group Inc
$15
Intercept Pharmaceuticals, Inc.
$13
Top 3 companies account for 53.5% of all-time payments
Associated products mentioned in payments ›
Axonics · CLENPIQ · COOK MEDICAL ENDOSCOPIC ULTRASOUND · CREON · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · DiLumen · ENTYVIO · EVIS EXERA III COLONOVIDEOSCOPE · EXALT Model D · EndoFlip · Entyvio · Epclusa · GATTEX · HUMIRA · Humira · INJECTAFER · INTERSTIM · Instinct · LINZESS · Linzess · MAVYRET · MONOFERRIC · Mavyret · Mulpleta · OCALIVA · OverStitch Endoscopic Suturing System · Overstitch · REBYOTA · RINVOQ · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · TERLIVAZ · TREMFYA · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
27
County median income
$65,715
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Newman is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Newman experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Newman performed 1,370 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Newman receive payments from pharmaceutical companies?
Yes. Dr. Newman received a total of $9,771 from 39 companies across 253 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Newman's costs compare to other gastroenterologists in Pensacola?
Dr. Newman's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Newman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Pensacola
Browse gastroenterologists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Apollo Endosurgery US Inc Payments to Doctors
See all physicians who received payments from Apollo Endosurgery US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology